Receptor autoradiography with the Y 2 receptor ligand 125 Ipeptide YY and in situ hybridization were applied to investigate changes in neuropeptide tyrosine-Y 2 receptor expression after kainic acid-induced recurrent seizures in the rat hippocampus. In the strata oriens and radiatum of CA1 to CA3, which are densely innervated by Y 2 receptor-bearing Schaffer collateral terminals, a transient 2-fold increase in Y 2 receptor affinity was observed after 4 -12 hr, with a later slow decline. No change was seen in Y 2 mRNA expression in CA2/CA3 pyramidal cells, from which Schaffer collaterals originate. Conversely, in granule cells of the dentate gyrus, markedly elevated Y 2 mRNA concentrations were observed (by 740% in the dorsal hippocampus) 24 -48 hr after kainate injection. At the same time, a marked and lasting (up to 6 months) increase in the number of Y 2 receptor sites (by 800%) was seen in the dentate hilus, which is innervated densely by mossy fibers. The early increase in Y 2 receptor affinity in Schaffer collaterals was accompanied by a 60% decrease in the EC 50 of peptide YY 3-36 in inhibiting K ϩ -stimulated glutamate release in hippocampal slices from kainic acid-treated rats. Our data indicate transient up-regulation of presynaptic Y 2 receptors in Schaffer collaterals by a change in affinity and a permanent de novo synthesis of presynaptic Y 2 receptors in granule cells/mossy fibers. These changes may cause augmented presynaptic inhibition of glutamate release from different hippocampal sites and, in conjunction with increased concentrations of neuropeptide tyrosine in mossy fibers, may represent an endogenous reactive anticonvulsant mechanism.
number of Y 2 receptor sites (by 800%) was seen in the dentate hilus, which is innervated densely by mossy fibers. The early increase in Y 2 receptor affinity in Schaffer collaterals was accompanied by a 60% decrease in the EC 50 of peptide YY 3-36 in inhibiting K ϩ -stimulated glutamate release in hippocampal slices from kainic acid-treated rats. Our data indicate transient up-regulation of presynaptic Y 2 receptors in Schaffer collaterals by a change in affinity and a permanent de novo synthesis of presynaptic Y 2 receptors in granule cells/mossy fibers. These changes may cause augmented presynaptic inhibition of glutamate release from different hippocampal sites and, in conjunction with increased concentrations of neuropeptide tyrosine in mossy fibers, may represent an endogenous reactive anticonvulsant mechanism.
Systemic injection of KA in the rat causes severe convulsions, seizure-induced brain damage, increased seizure susceptibility, and, after several weeks, spontaneous recurrent seizures (Ben-Ari, 1985; Sperk, 1994) . These sequelae closely resemble those of human temporal lobe epilepsy. Therefore, KA-induced epilepsy has become a widely accepted animal model for this neurological disorder (Ben-Ari, 1985; Nadler, 1981) . In this animal model, as in the human condition, the dentate gyrus of the hippocampus is presumed to be intimately involved in the generation of epileptic activity and exhibits characteristic neurochemical and histopathological changes (Sperk, 1994) . Within granule cells of the dentate gyrus, immediate-early genes, neurotrophins, and various neuropeptides become strongly expressed during and after KA-induced seizures [for a review, see Sperk (1994) ]. The expression of most of these molecules is transient. However, a persistent increase in the concentrations of NPY and its mRNA is seen in granule cell/mossy fibers (Bellmann et al., 1991; Sperk et al., 1992) , and we recently proposed that this may represent a possible endogenous anticonvulsant mechanism (Greber et al., 1994; Sperk et al., 1992) .
It is well accepted that in the hippocampus, NPY-Y 2 receptors are located mainly presynaptically on terminals of Schaffer collaterals (Dumont et al., 1996; Haas et al., 1987) . They are prejunctionally innervated by NPY/GABA neurons (Haas et al., 1987; Milner and Veznedaroglu, 1992) and mediate presynaptic inhibition of glutamate release from Schaffer collaterals (Colmers et al., 1991; Greber et al., 1994; Haas et al., 1987) . The same receptors seem to be minimally expressed on mossy fiber terminals (Dumont et al., 1996; Röder et al., 1996) .
We recently observed increased NPY receptor binding in various hippocampal subfields of rats subjected to KA-induced seizures (Röder et al., 1996) . To investigate these changes in NPY receptor binding in detail, we applied in situ hybridization to study Y 2 receptor mRNA expression and determined kinetic parameters (K d and B max ) for the binding of 125 I-PYY 3-36 , a specific Y 2 receptor agonist, in the terminal areas of Schaffer collaterals (strata oriens/radiatum of CA1) and mossy fibers (hilus of the dentate gyrus). Furthermore, we investigated the changes in Y 2 receptor-mediated presynaptic inhibition of glutamate release from hippocampal slices ex vivo obtained 4 hr after KA injection.
determination of glutamate and LiChrospher 100RP-8, 5 m, 250 ϫ 4 mm, for separation of radioiodinated peptides) were purchased from Merck (Darmstadt, Germany). KA, the constituents of the hybridization buffer (Ficoll, polyvinylpyrrolidone, bovine serum albumin, salmon sperm DNA, yeast tRNA, dithiothreitol, dextran sulfate), and bacitracin were obtained from Sigma Chemical (St. Louis, MO). Bovine serum albumin, chloramine T, and cresyl violet originated from Serva (Heidelberg, Germany). Oligonucleotides were custom synthesized by Microsynth (Balgach, Switzerland). NPY, NPY 1985) . The experiments were performed with the consent of the Committee for Animal Protection of the Austrian Ministry of Science.
Rats were injected with 10 mg/kg KA intraperitoneally in buffered saline or with the corresponding amount of saline. As described in detail previously, KA initiated an acute behavioral syndrome that ranges from early staring, "wet dog shakes," and seizures from mild forehead nodding to severe limbic convulsions with rearing and foaming at the mouth (Sperk et al., 1983) . Rats were observed for Ն3 hr, and their behavior was rated as described previously (Sperk et al., 1983) . Animals exhibiting sustained limbic seizures (rating, 3-4; occurring in Ͼ80% of rats) were included in the studies. Depending on the experiment, rats were decapitated after different time intervals (4, 6, or 12 hr; 1, 2, or 7 days; and 1 and 6 months after KA injection). For in situ hybridization and receptor autoradiography, brains were rapidly removed from the skulls, divided by coronal cuts into three parts, immersed into cold isopentane (Ϫ40°C for 90 sec), and stored in sealed counting vials at Ϫ70°. For release studies, the hippocampi were dissected immediately on removal of the brains.
Brain sections. For in situ hybridization and Y 2 receptor autoradiography, 20-m-thick coronal sections of the dorsal hippocampus and horizontal sections of the ventral hippocampus were cut and thaw-mounted onto gelatin-coated slides. The sections were kept desiccated at Ϫ30°until their use in the respective experiments.
In situ hybridization. Two different synthetic oligonucleotide DNA probes were used (GAGTGAATGGCATCCAACCTCTGCTCA-CAGCGGAAGGCTGAGAGG and TGCTTGGAGATCTTGCTCTC-CAGGTGGTAGACAATGCAACGATGTCGGTCC). The probes were complementary to different sequences of the rat Y 2 receptor mRNA (Dr. H. Herzog, personal communication, 1997) and highly homologous to the bases 1020-1064 and 451-501 of the recently published mouse cDNA, respectively (Nakamura et al., 1996) . Essentially, the same results were observed with both probes; data obtained with the later one are shown. The oligonucleotides were labeled with [ 35 S]␣-thio-dATP (1300 Ci/mmol) via reaction with terminal deoxynucleotidyltransferase and precipitated with ethanol/sodium chloride. Matching sections from the same portion of the hippocampus of KA-treated rats and controls were assayed together. Frozen sections were rapidly immersed into 2% paraformaldehyde in phosphatebuffered saline (150 mM NaCl in 10 mM phosphate buffer, pH 7.2) for 10 min at room temperature, rinsed in phosphate-buffered saline, immersed in 0.25% acetic anhydride in 0.1 M triethylamine hydrochloride for 10 min, dehydrated by ethanol series, and delipidated with chloroform. They were hybridized at 42°for 18 hr with Ϸ50 fmol (1-1.5 ϫ 10 6 cpm) labeled oligonucleotide probe in 50 l of hybridization buffer consisting of 50% formamide, 5ϫ SSC (1ϫ SSC ϭ 150 mM NaCl, 15 mM sodium citrate, pH 7.2), 500 g/ml salmon sperm DNA, 250 g/ml yeast tRNA, 1ϫ Denhardt's solution (0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulfate, and 20 mM dithiothreitol. At the end of the incubation, the slides were briefly rinsed twice in 1ϫ SSC/50% formamide. They were washed four times in 50% formamide in 2ϫ SSC (42°for 15 min), rinsed in 1ϫ SSC, and dipped briefly in water. The sections were then dipped in 70% ethanol, dried, and exposed to ␤max films for 2 weeks. Subsequently, the slides were dipped in Kodak NTB-2 photosensitive emulsion (diluted 1:1 with distilled water), air-dried, and exposed for 6 weeks. The ␤max films and dipped slides were developed with Kodak D19 developer. Sections were counter-stained superficially with cresyl violet, dehydrated, cleared in xylol, and coverslipped with Entellan. The corresponding radiolabeled sense DNA was used to exclude nonspecific hybridization of the probe. Sections prehybridized for 2 hr with an excess (1 nmol) of unlabeled probe were included as additional controls in some experiments.
Preparation of 125 I-PYY 3-36 . PYY 3-36 was radiolabeled according to the procedure of Hunter and Greenwood (1962) as described previously in greater detail for NPY (Bellmann et al., 1991; Dumont et al., 1995) . Briefly, 10 g of PYY 3-36 was allowed to react with 1 mCi of 125 I (2200 Ci/mmol), 30 g of chloramine T in 10 l of H 2 O, and 60 l of 0.5 M phosphate buffer, pH 7.0, at room temperature for 45 sec. The reaction was stopped by the addition of 100 l of 10% bovine serum albumin. The resulting mixture was separated on a C8 reverse-phase column (LiChrospher 100RP-8, 5 m, 250 ϫ 4 mm) by HPLC, which was eluted with 0.1 M tetraethyl-formiate buffer, pH 2.5, and acetonitrile (application of a linear gradient from 25% to 40% during 55 min) at a flow rate of 1.0 ml/min. Two major radioactive peptide peaks were recovered at 30% and 32% acetonitrile; they exhibited similar binding properties, and aliquots of the first peak were used. Because the terminal tyrosine becomes preferentially iodinated and migrates early on HPLC (Sheikh et al., 1989) Dumont et al. (1996) . Slides containing either one brain section (time course study) or three sections placed on the same slide (kinetic analysis and displacement studies) were thawed and preincubated for 30 min at room temperature in 200 ml of Krebs-Henseleit-Tris buffer (118 mM NaCl, 4.8 mM KCl, 1.3 mM MgSO 4, 1.2 mM CaCl 2 , 50 mM glucose, 15 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 10 mM Tris, pH 7.3). The incubation was performed in Coplin jars containing 20 ml of the same buffer supplemented with 0.1% bovine serum albumin, 0.05% bacitracin, and 125 I-PYY 3-36 . Time course studies were performed at 25 pM 125 I-PYY 3-36 . Kinetic analysis of the receptor binding was performed in sections of the dorsal hippocampus of controls and 6 or 48 hr after KA injection. 125 I-PYY 3-36 was used at concentrations of 2.5, 5, 10, 15, and 25 pM. Displacement studies were performed at 25 pM ]PYY, or PP or 5 or 15 M concentration of the Y 1 antagonist BIBP 3226 was included in the incubation medium. Incubations were performed at room temperature for 2 hr. Unspecific binding was determined in the presence of 1 M NPY; it was uniformly distributed throughout the section and was Ͻ5% (e.g., in Schaffer collaterals). The sections were dipped twice and then washed for 30 sec in ice-cold Krebs-Henseleit-Tris buffer, dipped in deionized water, and rapidly dried under a stream of cold air. They were exposed to ␤max films for 10 days together with 125 I-microscales. Quantification of in situ hybridization and receptor autoradiography and statistics. The autoradiograms were developed, Y 2 Receptor Up-Regulation in Epilepsy digitized through the Appligene Image System (Illkirch, France), and analyzed using the public domain NIH Image program (written by Wayne Rasband at the National Institutes of Health and available from the Internet by anonymous FTP from zippy.nimh.nih.gov). For quantification of mRNA signals, absorbance was quantified in the strata granulosum and pyramidale. For each rat, values obtained for both sides were averaged. Data are given as mean values obtained from 3-6 animals per time interval and 12 age-matched control animals. For binding experiments, absorbance was measured in the strata oriens and radiatum of CA1 and in the hilus of the dentate gyrus. Absolute values were calculated by using a doseresponse curve of the absorbance obtained through concomitant autoradiography of 125 I-microscales and expressed as fmol/mg of wet tissue weight. Specific binding was calculated by subtracting the unspecific binding, as determined in the presence of 1 M NPY, from total binding. For the time course study, mean values obtained from pairs of hippocampi were averaged for each time interval after KA injection (3-6 rats/interval) and from 12 age-matched control animals killed concomitantly with the experimental animals. For displacement studies, mean values determined in three to six sections per animal were averaged. These values were used for calculating the mean values for 5 rats. Data are expressed as percentage of 125 I-PYY 3-36 binding in the presence of the respective unlabeled peptide analog of control binding obtained in the absence of cold ligands using sections from the same rats. Statistical analysis was done for time course and displacement studies by analysis of variance and the multiple-comparison Dunnett posteriori test.
Kinetic evaluation was performed separately for each animal using Scatchard blot analysis for the strata oriens and radiatum CA1 and the dentate hilus. For each concentration of 125 I-PYY 3-36 , binding was determined in nine coronal sections of the dorsal hippocampus per animal (three sections per slide). Values of individual sections were obtained by calculating the mean values of each hemisphere. Mean unspecific binding for each ligand concentration was assessed in 35 sections and deducted. K d and B max values were determined individually for each animal using regression analysis. Data were averaged, and a two-tailed Student's t test was used for statistical comparison.
Cell counts were performed to evaluate relative cell loss in interneurons of the hilus of the dentate gyrus, CA1, CA3a, and CA3c pyramidal neurons. Counts were performed in 20-m Nissl-stained sections of the dorsal hippocampus in areas of 25,000 m 2 (CA1 and CA3a) and 100,000 m 2 (hilus and CA3c), respectively. Superfusion of hippocampal slices. Superfusion experiments were performed as described previously (Greber et al., 1994) . Control and KA-treated rats (4 hr after treatment) were killed by decapitation. Their brains were rapidly removed and transferred into ice-cold Krebs-Henseleit-Tris buffer (118 mM NaCl, 4.8 mM KCl, 1.3 mM MgSO 4 , 1.2 mM CaCl 2 , 15 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 10 mM Tris, 10 mM glucose, adjusted to pH 7.3 by gassing with 95% O 2 /5% CO 2 ). Hippocampi were dissected keeping brains immersed in chilled buffer. Slices (300 m) of the septal extension of the hippocampus were obtained using a McIllwain tissue chopper and placed in superfusion chambers at 34° (Greber et al., 1994) . They were superfused at a flow rate of 1.0 ml/min with the above buffer and continuously gassed with 95% O 2 /5% CO 2 . Glutamate release was provoked by increasing the K ϩ concentration to 45 mM for 90 sec while the Na ϩ concentration was correspondingly reduced. Slices were stimulated twice (after 50 and 100 min, respectively). PYY 3-36 was included at concentrations of 0, 1, 3, 10, 30, or 100 nM together with 0.01% bovine serum albumin in the superfusion medium 8 min before and during the second K ϩ pulse. Fractions of 1.0 ml were collected, lyophilized, and used for determination of glutamate. Brain slices were finally sonicated in 1.0 ml of 0.1 M HClO 4 . This homogenate was centrifuged and the supernatants were diluted 1:80 with 0.4 M NaBO 4 buffer, pH 8.4, for determination of tissue glutamate. Pellets were solubilized in 100 l of 0.5 M NaOH (20 min, 90°) and assayed for protein content (Lowry et al., 1951) .
Determination of glutamate by HPLC. Glutamate was determined by HPLC and fluorimetric detection after precolumn derivatization with o-phtaldialdehyde as described in detail previously (Greber et al., 1994) . Basal release rates were defined by the mean glutamate concentrations of two fractions before and two fractions after stimulation. Potassium stimulated glutamate release was calculated by the glutamate concentration in the two fractions obtained during stimulation with high K ϩ and subtraction of basal release. The ratio of potassium stimulated glutamate release during the second and the first stimuli (S 2 /S 1 ) was calculated. Dose-response curves and EC 50 values were calculated by sigmoidal analysis using the computer program Origin 4.1.
Results
Behavioral and neuropathological changes. On injection of KA, rats exposed a typical limbic seizure syndrome, characterized by early staring, "wet dog shakes," and seizures ranging from mild forehead nodding to severe limbic convulsions with rearing and foaming at the mouth, as described in more detail previously (Sperk, 1994; Sperk et al., 1983) . Maximal seizure activity was observed in Ͼ80% of the rats between 1 and 2 hr after KA injection and declined thereafter. Physically, the rats recovered entirely after Ϸ1 week. Rats exhibiting the full seizure syndrome were included in the study. These rats exposed typical neurodegenerative changes in the hippocampal formation (Beu-Ari, 1985; Sperk, 1994) . Two days after injection of KA, neurodegeneration was evident by loss of interneurons of the dentate hilus (by 68 Ϯ 9.9%; mean Ϯ standard error) and pyramidal cells in CA1 (by 38 Ϯ 12.5%), CA3a (by 53 Ϯ 8.8%), and CA3c (by 75 Ϯ 9.9%). At the early intervals (4-6 hr after KA injection), neuronal damage was not detected.
In situ hybridization of Y 2 receptor mRNA. In control rats, Y 2 receptor mRNA was expressed preferentially in the pyramidal cell layers of CA3 and CA2 of the dorsal and ventral hippocampus (Figs. 1, 2, and 3) . Although the transcript was essentially absent in the CA1 pyramidal neurons and in granule cells of the dorsal hippocampus, it was observed in the respective neurons of the ventral hippocampus, indicating a septotemporal gradient of Y 2 mRNA expression. After KA injection, high concentrations of Y 2 receptor mRNA were found in granule cells of both extensions of the hippocampus (Figs. 1 and 2) . Expression of the receptor mRNA was maximally increased after 24 hr in the dorsal (by Ϸ740%; Fig. 3 ) and after 48 hr in the ventral hippocampus (by Ϸ190%). It declined slowly thereafter but remained significantly elevated even 30 days after injection of the convulsant (Fig. 3) . In the ventral hippocampus, the increase in Y 2 receptor mRNA in granule cells was preceded by an initial decrease (by 73% of control) in message 4-6 hr after KA injection ( Figs. 1 and 2 ). In CA1, slight and transient expression of Y 2 receptor mRNA was detected after 24-48 hr (Fig.  1 (Fig. 4) . Considerably lower concentrations were observed in all other areas of the hippocampus, including the hilus and the molecular layer of the dentate gyrus. Only a thin band in the supergranular zone of the inner molecular layer of the dentate gyrus was labeled.
In agreement with our previous experiments using fulllength 125 I-PYY (Roden et al., 1996) , a rapid and pronounced increase in binding of the Y 2 receptor specific agonist 125 I-PYY 3-36 was observed in the strata oriens and radiatum of CA1 to CA3 (Figs. 3 and 4 for stratum oriens in the dorsal hippocampus). In this area, binding was maximally elevated 4-12 hr after KA injection (by 80-100%; Fig. 3 ) and decreased (by 50%) below control levels after 1 month. In the hilus of the dentate gyrus, 125 I-PYY 3-36 binding increased more slowly but dramatically. It was maximally elevated after 24-48 hr, as shown in Fig. 3 for the dorsal hippocampus. Although essentially absent in the hilus of controls, the extent of 125 I-PYY 3-36 binding was then comparable to that in the strata oriens and radiatum (Figs. 3 and 4) . At later intervals, receptor binding decreased also in the hilus but remained elevated 3-fold even 6 months after KA injection (Fig. 3) . After 8-30 days, binding in the stratum lucidum (presumably located on mossy fiber terminals) remained increased despite its decline in the adjacent stratum radiatum. Although in the molecular layer of the dentate gyrus of controls Y2 receptor binding was restricted to the inner molecular layer, moderate binding was detected throughout the molecular layer 1-2 days after KA injection (Fig. 4) .
Kinetic analysis of Y 2 receptor binding. The distinctly different expression of Y 2 receptor mRNA in granule cells versus CA3 pyramidal neurons and the different time courses of changes in Y 2 receptor binding in the hilus compared with the strata radiatum and oriens suggest different mechanisms of Y 2 receptor up-regulation in granule cells/ mossy fibers and in CA3 pyramidal neurons/Schaffer collaterals. To investigate this in more detail, we conducted kinetic analysis of 125 I-PYY 3-36 receptor autoradiography 6 hr after KA injection in the strata oriens and radiatum of CA1 (representing terminal areas of Schaffer collaterals) and after 48 hr in the hilus of the dentate gyrus (a terminal area of mossy fibers that is not overlapping with Schaffer collaterals). Six In controls, Y 2 receptor mRNA is highest in CA2/CA3. In the ventral hippocampus, the transcript is also detected in CA1 and the stratum granulosum. Arrowheads, marked increase in Y 2 receptor mRNA in the granule cell layer after 12 and 48 hr (h) in the ventral and dorsal hippocampus, respectively, which is still present after 8 days (d) (shown for the ventral hippocampus). Scale bar, 2 mm. Fig. 2 . High-magnification, dark-field photographs of photoemulsiondipped sections of the ventral hippocampus after in situ hybridization of Y 2 receptor mRNA. In controls (Cont), the highest mRNA concentrations are present in the pyramidal cell layer of CA2/CA3. Lower concentrations are found in CA1 and the granule cell layer. At 6 hr (h) after KA-induced seizures, a reduction in Y 2 receptor mRNA is seen in the granule cell layer. At later intervals (24 hr), a marked increase in mRNA is seen in the same cells. At this interval, there is more message present in the suprapyramidal than in the infrapyramidal blade of the stratum granulosum. Scale bar, 20 m.
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at ASPET Journals on August 27, 2017 molpharm.aspetjournals.org Downloaded from hours after KA injection, a 2-fold increase in the affinity of 125 I-PYY 3-36 binding without a significant change in the number of receptor sites was observed in CA1 ( Fig. 5A ; Table  2 ). The change in K d was transient and returned to control levels after 2 days (data not shown). In contrast, in the hilus of the dentate gyrus, a marked (9-fold) increase in the number of Y 2 receptor sites was detected 2 days after KA injection ( Fig. 5B ; Table 2 ). Binding affinity was unchanged in this area.
Altered Y 2 receptor-mediated inhibition of glutamate release. This experiment was designed to investigate whether the increased Y 2 receptor affinity may result in increased efficacy of a Y 2 receptor agonist to inhibit glutamate release from Schaffer collaterals. The experiments were done in slices of the dorsal hippocampus from rats 4 hr after KA injection where they contained essentially no detectable Y 2 receptor mRNA or Y 2 receptor binding in the granule cell/mossy fiber system (Figs. 3 and 4) . Thus, modulation of Table 2 . The rate of K ϩ -stimulated glutamate release in the absence of PYY 3-36 was 550 Ϯ 47 (35 experimental points) and 1060 Ϯ 71 (37 experimental points) pmol/mg of protein/90-sec stimulus (mean Ϯ standard error) in control and KA-treated rats, respectively. As shown in Fig. 6 , the Y 2 receptor agonist PYY 3-36 , in a sigmoidal dose-response relationship, reduced K ϩ -stimulated glutamate release by up to 47% in both control and KA-injected rats. In slices from KA-treated rats, PYY 3-36 inhibited K ϩ -stimulated glutamate release at significantly lower concentrations than in slices of control rats (Fig. 6) . EC 50 values for PYY 3-36 -mediated inhibition of glutamate release were 10.5 Ϯ 0.61 nM (35 experimental points) and 4.2 Ϯ 0.13 nM (37 experimental points) (mean Ϯ standard error) in control and KA-treated rats, respectively.
Discussion
In accordance with our previous study (Röder et al., 1996) , the current results indicate a marked increase in Y 2 receptor binding in the hippocampus of rats after KA induced limbic seizures. Our data demonstrate that these changes are mediated by two regionally different mechanisms: (1) a fast increase in affinity of Y 2 receptors in the strata oriens and radiatum (presumably located there on Schaffer collaterals) and (2) (Bard et al., 1995; Blomqvist and Herzog, 1997; Gerald et al., 1996; Hu et al., 1994) Weinberg et al., 1996) . Taken together, these studies indicate that 125 I-PYY 3-36 under our conditions may bind mainly to Y 2 receptors. Furthermore, the affinities of PYY 3-36 to Y 5 and Y 4 receptors are Ϸ7-fold and Ͼ1000-fold lower than for Y 2 receptors, respectively (Bard et al., 1995; Blomqvist and Herzog, 1997; Gerald et al., 1996) , and the distribution of Y 2 receptors is in excellent agreement with the in situ hybridization data using a Y 2 -specific probe.
Increased affinity of Y 2 receptors in Schaffer collaterals. The dense binding sites for 125 I-PYY 3-36 within the strata oriens and radiatum could be located either on dendrites of pyramidal neurons or terminals of Schaffer collaterals arising from CA3. There is, however, considerable evidence for prejunctional Y 2 receptors located on Schaffer collaterals. Milner and Veznedaroglu (1992) demonstrated NPY-containing terminals near axon terminals in the stratum oriens of CA1 and CA3. Electrophysiological evidence for a presynaptic localization of Y 2 receptors on terminals of Schaffer collaterals and their presynaptic inhibitory action on glutamate release was provided previously (Colmers et al., 1985 (Colmers et al., , 1991 Haas et al., 1987) , and Y 2 receptors have been found especially enriched in the strata oriens and radiatum of CA1 to CA3 (Dumont et al., 1996) (Figs. 3 and 4) . Further support for a presynaptic localization of Y 2 receptors on Schaffer collaterals comes from the in situ hybridization data. The highest concentrations of Y 2 receptor mRNA are contained in CA3 and CA2 neurons. The fact that minor amounts of Y 2 mRNA are also expressed in CA1 neurons of the ventral hippocampus and, 48 hr after KA injection in the dorsal hippocampus indicates either that some Y 2 receptors may be also present on dendrites of CA1 pyramidal neurons or, more likely, that they become targeted to terminals of CA1-subicular projection neurons.
KA seizures induce a rapid increase in Y 2 receptor binding (after 4-12 hr) without a concomitant increase in concentrations of the respective mRNA in pyramidal cells. These observations argue against enhanced synthesis of Y 2 receptors in Schaffer collaterals as a cause for the increased receptor binding. Accordingly, kinetic analysis of 125 I-PYY 3-36 receptor binding in this area revealed an increase in receptor affinity without a significant change in the number of binding sites. This change in affinity likely may be caused by post-translational modification. Indeed a cysteine, as a pos- molpharm.aspetjournals.org sible site for palmitoylation, and several serine residues, which might be involved in regulatory phosphorylation, are present in the receptor molecule (Rose et al., 1995) .
Increased affinity of Y 2 receptors may facilitate presynaptic inhibition of glutamate release from Schaffer collaterals. The decreased EC 50 values found for PYY in presynaptic inhibition of glutamate release are in good agreement with the increased affinity of Y 2 receptors in the binding studies and thus indicates a mechanism pertinent to the pathophysiology of KA-induced epilepsy. In control animals and 4 hr after KA injection, almost no Y 2 receptors are present on mossy fibers, and only a minor portion of Y 2 binding is present in the dentate molecular layer. Therefore, glutamate released from mossy fibers may largely contribute to the portion of glutamate release not responding to the Y 2 receptor agonist.
It is interesting to note that in slices from KA-treated rats, there was an almost 2-fold increase in basal K ϩ -stimulated glutamate release. This certainly is an indicator for the markedly enhanced excitatory transmission in these rats. Despite this, similar inhibition of glutamate release, by Ϸ50%, was seen in control and KA-treated rats at maximal concentrations (100 nM) of the Y 2 receptor agonist.
Elevated Y 2 receptor synthesis in granule cells/ mossy fibers. In the stratum lucidum, Y 2 receptor binding to mossy fibers overlaps with the strong labeled area of Schaffer collaterals. Binding to mossy fibers was therefore investigated in the hilus of the dorsal dentate gyrus, in which essentially no Y 2 receptors are present in controls. Thus, the concomitant pronounced increases in Y 2 receptor mRNA concentration in granule cells and of the number of Y 2 receptor sites in the hilus of the dentate gyrus are clear indicators of newly synthesized receptors. Essentially no Y 2 receptor mRNA was observed in interneurons of the dentate gyrus of control and KA-treated rats, excluding an other possible localization of Y 2 receptor binding in the hilus. Y 2 receptor mRNA occurs rather early (already after 12 hr) and throughout the granule cell layer. It is not restricted to newly formed granule cells, which are found primarily at the inner surface of the granule cell layer and can be labeled after 3-13 days by incorporation of deoxyuridine (Parent et al., 1997) .
In the ventral aspect of the hippocampus (in which in control animals, measurable concentrations of Y 2 receptor mRNA are present), the increase of Y 2 receptor transcript is preceded by an early (4-6 hr after KA injection) decrease in message. This indicates high lability and fast turnover of the transcript. As observed for the Ammon's horn, in the dentate hilus, the increase in Y 2 receptor binding becomes attenuated after some time. Concentrations of Y 2 receptor mRNA in granule cells and Y 2 receptor binding in the dentate hilus remain significantly elevated 1-6 months after the KA-induced seizures, indicating permanent expression of these receptors in epileptic rats.
To which mechanisms in epileptogenesis do the changes in Y 2 receptors relate? Changes in Y 2 receptor binding and mRNA expression could be either initiated by the strong and repeated neuronal stimulation during or after acute KA-induced seizures or may be related to adaptive changes in the course of epileptogenesis (Sperk, 1994) . Similar to the augmented expression of NPY in mossy fibers (Marksteiner et al., 1990) , we are proposing extensive stimulation during epileptic seizures as a primary mechanism.
Thus, increases in Y 2 binding in Schaffer collaterals are already maximal before extended neurodegeneration or subsequent plastic changes of mossy fibers are detected. Furthermore, we recently observed similar expression of Y 2 receptor mRNA and binding in granule cells/mossy fibers of electrically kindled rats that are devoid of neuronal damage (Gobbi et al., in press) .
It is interesting to note that in our current work (using KA-treated rats), there even was a tendency for a negative correlation of Y 2 binding in the hilus of the dentate gyrus and neuronal damage occurring at the same time in CA3c neurons (preliminary data, not shown), indicating a possible protective effect in rats with increased Y 2 receptor expression in granule cells/mossy fibers.
On the other hand, it must be noted that the late decreases in Y 2 receptor binding in the strata oriens and radiatum may be due to neurodegenerative processes. As shown in our previous experiments (Röder et al., 1996) , in animals treated with thiopental early after seizure induction to prevent neurodegeneration, similar but more persistent increases in NPY receptor binding can be seen.
NPY may mediate an endogenous anticonvulsive action through Y 2 receptors. It is well established that the hippocampal formation plays a crucial role in the generation and propagation of seizures in temporal lobe epilepsy (Nadler, 1981; Sommer, 1880) . In the hippocampus of control rats, NPY is contained within numerous GABAergic interneurons (Köhler et al., 1986) . Some of these interneurons are terminating prejunctionally on Schaffer collaterals (Milner and Veznedaroglu, 1992) . In CA3 and CA1, NPY inhibits glutamate release from these fibers through Y 2 receptors (Colmers et al., 1991) . During the acute seizures, reaching their maximal extent Ϸ90 min after KA injection, a rapid decrease in NPY levels indicates pronounced release of the peptide (Bellmann et al., 1991) . In conjunction with the rapid increase in Y 2 receptor affinity, this may represent an important mechanism for suppressing excessive glutamate release from Schaffer collaterals and counteracting the spread of excitation through the hippocampal circuits. The possible relevance of this mechanism is underscored by our current work on glutamate release ex vivo. Furthermore, NPY infused into the brain has a potent anticonvulsive action (Smialowska et al., 1996; Woldbye et al., 1996) , and NPY-deficient mice exhibit an increased seizure susceptibility (Erickson et al., 1996) .
Mossy fibers exert an important role in passing the afferent excitatory information of the perforant path to CA3 pyramidal neurons. Because granule cells are resistant to seizure-induced brain damage, they are prone to chronically perpetuate excitation in the epileptic animals. Thus, expression of NPY and its presynaptic Y 2 receptors in mossy fibers may result in presynaptic inhibition of glutamate release; this may aid in attenuating the excitatory/excitotoxic action of glutamate on CA3 pyramidal neurons. Considering the highly effective action of NPY on glutamate release ex vivo, this may be a rather important mechanism in the epileptic animal.
In contrast to NPY released from GABA/NPY interneurons and acting presynaptically on Schaffer collaterals, NPY released from mossy fibers acts at its own nerve terminals. Thus, its rate of release and its final action are controlled by the activity of mossy fibers themselves. Within mossy fiber terminals, the peptide presumably is stored in large dense core vesicles. Although under physiological conditions or low frequency stimulation, primarily the small synaptic vesicles (containing glutamate but no peptides) become exocytosed, NPY can be released from large, dense core vesicles at high frequency stimulation (for a review, see Hökfelt, 1991) . This indicates that the peptide will be primarily liberated during episodes of acute seizures and may not interfere significantly with the physiological transmission of the hippocampus during seizure-free intervals. Expression of NPY and its receptors in mossy fibers therefore may represent a potent endogenous anticonvulsive mechanism that may be programmed to become particularly activated during acute seizure episodes.
